Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
  • Challenge: Developing novel diagnostic strategies

Oxford cancer researchers are working with large clinical datasets to identify which patient groups are likely to benefit from new technologies and modelling how to deploy these new tests in general practice to realise maximum patient benefit. We are building clinical risk prediction models to inform automated patient identification in NHS systems, and applying insights from major external collaborations (e.g. the DELTA project with Cambridge, and ADEPTS project with UCL, in oesophageal and pancreatic cancer respectively).